Intersession reliability of lower limb muscle strength assessments in adults with obesity eligible for bariatric surgery.

BACKGROUND: The aim of this study was to examine the test-retest reliability in lower limb muscle strength and rate of torque development (RTD) using isokinetic dynamometry in adults with obesity, with a body mass index (BMI) ≥ 35 kg/m2. METHOD: Thirty-two adults with a BMI of 43.8 ± 6.6 kg/m2 eligible for bariatric surgery were enroled in the study. Isokinetic and isometric knee extensor (KE) and flexor (KF) strength were assessed in an isokinetic dynamometer (Biodex 4) during three test sessions separated by 3-7 days. RESULTS: There were no statistical differences in peak KE and KF torque for any test modalities between sessions. Intraclass correlation (ICC) was 0.91-0.94 between sessions 1 and 2 and 0.94-0.97 between sessions 2 and 3. Standard error of measurement (SEM%) and coefficient of variation (CV) ranged across test sessions from 4.3% to 7.3%. KE RTD showed high test-retest reliability following familiarization, with ICC, CV and SEM% values ranging from 0.84 to 0.90, 13.3%-20.3% and 14.6%-24.9%, respectively. CONCLUSION: Maximal lower limb muscle strength measured by isokinetic dynamometry showed excellent test-retest reliability manifested by small measurement errors and low CV. Reliability was slightly improved by including a familiarization session. KE RTD but not KF RTD demonstrated high test-retest reliability following familiarization. The present data indicate that isokinetic dynamometry can be used to detect even small changes in lower limb muscle strength in adults with obesity.

Accelerated loss of lean body mass in head and neck cancer patients during cisplatin-based chemoradiation.

BACKGROUND: This study investigated changes in body weight, lean body mass (LBM), fat mass (FM), muscle strength and functional performance during radiation treatment in head and neck cancer (HNSCC) patients. Secondly, it investigated the impact of cisplatin-based chemoradiation (CCRT) on LBM loss compared with radiation alone. METHODS: 48 patients (all tumor sites) received either 6 weeks of radiation alone (n = 16) with 66-68 Gy in 33-34 Fx, 5-6 Fx/week or CCRT, adding weekly cisplatin or carboplatin (n = 32). LBM and FM was evaluated using Dual-energy X-ray Absorptiometry bi-weekly from pre- to two weeks post-treatment. Maximal muscle strength (knee extension, leg - and chest press) and functional performance (stair climb, chair rise, and arm curl) were assessed pre- and post-treatment. RESULTS: Body weight and LBM had declined significantly already week 2 into treatment and declined significantly further through week 4 and 6 before leveling off after week 6. Bi-weekly, from treatment start to week 2, 2-4, and 4-6, LBM declined 1.2 ± 0.4 kg (p = .002; 95% CI: 0.4;2.0), 2.0 ± 0.4 kg (p < .0001; 1.2;2.8) and 1.4 ± 0.4 kg (p = .001; 0.6;2.2). With a two-week delay, FM declined significantly from week 2-8. All measures of muscle strength declined significantly from pre- to post-treatment. Functional performance was unchanged. LBM loss from pre- to post-treatment was significantly associated with impaired muscle strength (R2 = 0.3-0.5). CCRT patients lost 3.1 ± 0.8 kg of LBM (p = .0001; 1.5;4.7) more from pre- to post-treatment compared with patients receiving radiation alone. Analyses adjusting for nimorazole, tumor stage, baseline BMI, mean radiation dose to constrictor muscles and oral cavity confirmed this. CONCLUSION: Accelerated and substantial LBM loss was already initiated within the first two weeks of treatment - before the onset of radiation-induced mucositis. LBM loss was associated with muscle strength impairment. Patients receiving CCRT experienced significantly larger LBM loss than patients receiving radiation alone. Registered on clinincaltrials.gov (Identifier: NCT05890859).

A Maximal Rowing-Ergometer Protocol to Predict Maximal Oxygen Uptake in Female Rowers.

BACKGROUND: Laboratory assessment of maximal oxygen uptake (V˙O2max) is physically and mentally draining for the athlete and requires expensive laboratory equipment. Indirect measurement of V˙O2max could provide a practical alternative to laboratory testing. PURPOSE: To examine the relationship between the maximal power output (MPO) in an individualized 7 × 2-minute incremental test (INCR-test) and V˙O2max and to develop a regression equation to predict V˙O2max from MPO in female rowers. METHODS: Twenty female club and Olympic rowers (development group) performed the INCR-test on a Concept2 rowing ergometer to determine V˙O2max and MPO. A linear regression analysis was used to develop a prediction of V˙O2max from MPO. Cross-validation analysis of the prediction equation was performed using an independent sample of 10 female rowers (validation group). RESULTS: A high correlation coefficient (r = .94) was found between MPO and V˙O2max. The following prediction equation was developed: V˙O2max (mL·min-1) = 9.58 × MPO (W) + 958. No difference was found between the mean predicted V˙O2max in the INCR-test (3480 mL·min-1) and the measured V˙O2max (3530 mL·min-1). The standard error of estimate was 162 mL·min-1, and the percentage standard error of estimate was 4.6%. The prediction model only including MPO, determined during the INCR-test, explained 89% of the variability in V˙O2max. CONCLUSION: The INCR-test is a practical and accessible alternative to laboratory testing of V˙O2max.

Effects of low load exercise with and without blood-flow restriction on microvascular oxygenation, muscle excitability and perceived pain.

This paper aimed to examine the acute effect of low-load (LL) exercise with blood-flow restriction (LL-BFR) on microvascular oxygenation and muscle excitability of the vastus medialis (VM) and vastus lateralis (VL) muscles during a single bout of unilateral knee extension exercise performed to task failure. Seventeen healthy recreationally resistance-trained males were enrolled in a within-group randomized cross-over study design. Participants performed one set of unilateral knee extensions at 20% of one-repetition maximum (1RM) to task failure, using a LL-BFR or LL free-flow (LL-FF) protocol in a randomized order on separate days. Changes in microvascular oxygenation and muscle excitability in VL and VM were assessed using near-infrared spectroscopy (NIRS) and surface electromyography (sEMG), respectively. Pain measures were collected using the visual analog scale (VAS) before and following set completion. Within- and between- protocol comparisons were performed at multiple time points of set completion for each muscle. During LL-BFR, participants performed 43% fewer repetitions and reported feeling more pain compared to LL-FF (p<0.05). Normalized to time to task failure, LL-BFR and LL-FF generally demonstrated similar progression in microvascular oxygenation and muscle excitability during exercise to task failure. The present results demonstrate that LL-BFR accelerates time to task failure, compared with LL-FF, resulting in a lower dose of mechanical work to elicit similar levels of oxygenation, blood-pooling, and muscle excitability. LL-BFR may be preferable to LL-FF in clinical settings where high workloads are contraindicated, although increased pain experienced during BFR may limit its application.HighlightsCompared to free flow (FF), neuromuscular fatigue mechanisms are accelerated during blood flow restricted (BFR) training. This can be observed as changes in microvascular oxygenation and muscle excitability occurring at a ∼43% faster mean rate during BFR compared to FF.BFR exercise seems to elicit the same level of neuromuscular fatigue as FF training within a shorter timeframe. This reduces total joint load and may be especially helpful in cases where high training volumes may be contraindicated (e.g. recovering from a sports injury or orthopedic surgery).

Zoledronic Acid for prevention of bone and muscle loss after BAriatric Surgery (ZABAS)-a study protocol for a randomized controlled trial.

BACKGROUND: Bariatric surgery has adverse effects on the muscular-skeletal system with loss of bone mass and muscle mass and an increase in the risk of fracture. Zoledronic acid is widely used in osteoporosis and prevents bone loss and fracture. Bisphosphonates may also have positive effects on skeletal muscle. The aim of this study is to investigate the effects of zoledronic acid for the prevention of bone and muscle loss after bariatric surgery.  METHODS/DESIGN: This is a randomized double-blind placebo-controlled study. Sixty women and men with obesity aged 35 years or older will complete baseline assessments before randomization to either zoledronic acid (5 mg in 100 ml isotonic saline) or placebo (100 ml isotonic saline only) 3 weeks before surgery with Roux-en-Y-gastric bypass (RYGB) or sleeve gastrectomy (SG). Follow-up assessments are performed 12 and 24 months after surgery. The primary outcome is changes in lumbar spine volumetric bone mineral density (vBMD) assessed by quantitative computed tomography (QCT). Secondary bone outcomes are changes in proximal femur vBMD assessed by QCT. Changes in cortical and trabecular bone microarchitecture and estimated bone strength will be assessed by high-resolution peripheral quantitative computed tomography (HR-pQCT). Cortical material bone strength at the mid-tibia diaphysis will be assessed using microindentation and fasting blood samples will be obtained to assess biochemical markers of bone turnover and calcium metabolism.  Secondary muscle outcomes include whole body lean mass assessed using dual-energy X-ray absorptiometry. Dynamometers will be used to assess handgrip, shoulder, ankle, and knee muscle strength. Short Physical Performance Battery, 7.6-m walking tests, 2-min walking test, and a stair climb test will be assessed as biomarkers of physical function. Self-reported physical activity level is assessed using International Physical Activity Questionnaire (IPAQ). DISCUSSION: Results from this study will be instrumental for the evidence-based care of patients undergoing bariatric surgery. TRIAL REGISTRATION: ClinicalTrials.gov NCT04742010. Registered on 5 February 2021.

Optimal and freely chosen paddling rate during moderate kayak ergometry.

Moderate paddling, as in long distance kayaking, constitutes an endurance activity, which shares energetic aspects with activities such as long distance running and road cycling. The aim of the present study was to investigate whether in moderate paddling there is a U-shaped relationship between oxygen uptake and stroke rate, and also whether elite kayakers apply a freely chosen stroke rate, which is energetically optimal. Eleven young male elite kayakers performed moderate kayak ergometry at preset target stroke rates of 65, 75, and 90 strokes min-1, and at a freely chosen stroke rate, while physiological responses including oxygen uptake were measured. The results showed that considering average values calculated across all participants, there was an approximately U-shaped relationship between oxygen uptake and target stroke rate with a minimum at 75 strokes min-1. The freely chosen stroke rate was 67.0 ± 6.1 strokes min-1. Thus, the freely chosen stroke rate, for the group in total, appeared to be lower and require higher oxygen uptake as compared to the energetically optimal preset target stroke rate. Eight out of 11 participants had a higher oxygen uptake (5.1% ± 6.7%, p = 0.028, across all participants) at their freely chosen stroke rate than at the preset target stroke rate, which resulted in the lowest oxygen uptake. In conclusion, an approximately U-shaped relationship between oxygen uptake and stroke rate for young elite kayakers during moderate ergometer kayaking was found. Additionally, the freely chosen stroke rate was systematically lower and, consequently, required higher oxygen uptake than the preset stroke rate, which resulted in the lowest oxygen uptake.

A Maximal Rowing Ergometer Protocol to Predict Maximal Oxygen Uptake.

PURPOSE: To examine the relationship between the maximal power output (MPO) in an individualized 7 × 2-minute incremental (INCR) test, average power in a 2k (W2k) rowing ergometer test, and maximal oxygen uptake (V˙O2max) and to develop a regression equation to predict V˙O2max. METHODS: A total of 34 male club rowers (age 18-30 y) performed a 2k and an INCR test in a Concept2 rowing ergometer to determine and compare MPO, W2k, and V˙O2max. RESULTS: No significant difference was found between V˙O2max measured during INCR or 2k test (P = .73). A very high correlation coefficient (r = .96) was found between MPO and V˙O2max and between W2k and V˙O2max (r = .93). Linear regression analyses were developed for predicting V˙O2max from MPO: (1) V˙O2max (mL·min-1) = 11.49 × MPO + 810 and V˙O2max from W2k: (2) V˙O2max = 10.96 × W2k + 1168. Cross-validation analyses were performed using an independent sample of 14 rowers. There was no difference between the mean predicted V˙O2max in the INCR test (4.41 L·min-1) or the 2k test (4.39 L·min-1) and the observed V˙O2max (4.40 L·min-1). Technical error of measurement was 3.1% and 3.6%, standard error of estimate was 0.136 and 0.157 mL·min-1, and validation coefficients (r) were .95 and .94 using Equation (1) and (2), respectively. CONCLUSION: A prediction model only including MPO or W2k explains 88% to 90% of the variability in V˙O2max and is suggested for practical use in male club rowers.